Latest Market News

Sep 14
The cryptocurrency market digest for 14.09.2022

The BTC has experienced a new decline. On Wednesday, the leading cryptocurrency is balancing near 20,303 USD though yesterday it rose to 22,780 USD. Yesterday the USD reversed abruptly after the US inflation statistics came out. The CPI in the US in August turned out to be 8.3% y/y while the forecast level had been […]

Sep 14
Discover Financial says it’s hiring for 2,000 customer-care roles

Discover Financial Services DFS, -0.02% said Wednesday that it was hiring for 2,000 additional customer care positions. The payments and banking company is looking to add employees in Arizona, Delaware, Illinois, Ohio, and Utah, per a press release. The company added that New Jersey, Pennsylvania, and Maryland residents would be eligible to take positions in […]

Sep 14
Pound: down again. Overview for 14.09.2022

The British pound against the US dollar dropped to the week’s lows. The current quote is 1.1499. Yesterday the pound looked rather optimistic, but on Wednesday with the USD advancing all positive factors for the GBP faded away. After the inflation statistics in the US came out, expectations from the September meeting of the Fed […]

Sep 14
Web3 is creating a new genre of NFT-driven music

Music-related use cases for Web3 technologies are piling up as the industry goes all in on adoption. From democratizing song rights royalties and blockchain licensing to legacy companies like Sony Entertainment filing patents for nonfungible token- (NFT)-authenticated music. While electronic dance music and pop seem to be picking up the most attention in terms of NFT music, […]

Sep 14
Twilio plans to slash 11% of jobs as part of cost-cutting program

Twilio Inc. TWLO, +4.53% said Wednesday that its board of directors has approved a restructuring plan that will see the company cut about 11% of its staff. The company, which makes software for customer communications, expects to take a $70 million to $90 million charge related to the restructuring plan and reflective of costs around […]

Sep 14
Altimmune’s stock falls 44% after sharing data from trial for liver disease treatment

Shares of Altimmune Inc. ALT, -37.39% tumbled 44.4% in premarket trading on Wednesday after the company shared new data from an early-stage clinical trial for its experimental treatment for non-alcoholic fatty liver disease that failed to impress investors. The Phase 1b study met both the primary and secondary endpoints of reduction in liver fat content […]